Detalhe da pesquisa
1.
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Lancet Oncol
; 25(2): 198-211, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38301689
2.
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lancet Oncol
; 23(6): 748-757, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35617989
3.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 22(5): 690-701, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33798493
4.
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Br J Cancer
; 124(4): 786-796, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33223535
5.
Adjuvant chemotherapy in colon cancer: state of the art and future perspectives.
Curr Opin Oncol
; 32(4): 370-376, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32541327
6.
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncol
; 20(5): 663-673, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30922733
7.
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lancet Oncol
; 22(7): e288-e289, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34197751
8.
Quality of life, long-term survivors and long-term outcome from the ABC-02 study.
Br J Cancer
; 114(9): 965-71, 2016 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27115567
9.
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Br J Cancer
; 115(4): 420-4, 2016 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27434036
10.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.
Lancet Oncol
; 15(6): 601-11, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24717919
11.
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 15(8): 829-40, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24954781
12.
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
J Clin Oncol
; : JCO2301648, 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38484206
13.
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
J Exp Clin Cancer Res
; 43(1): 64, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38424636
14.
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
N Engl J Med
; 362(14): 1273-81, 2010 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-20375404
15.
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
J Pathol Clin Res
; 9(6): 449-463, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37697694
16.
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
JAMA Oncol
; 9(2): 188-196, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36547970
17.
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
J Clin Oncol
; 40(18): 2048-2057, 2022 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35316080
18.
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Eur J Cancer
; 175: 1-10, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36084618
19.
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer.
JNCI Cancer Spectr
; 5(1)2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34159294
20.
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis.
Clin Colorectal Cancer
; 20(3): 236-244, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33992542